# ImmunoPET Imaging of Pancreatic Cancer

> **NCT06602037** · NA · RECRUITING · sponsor: **RenJi Hospital** · enrollment: 90 (estimated)

## Conditions studied

- Neoplasms Pancreatic

## Interventions

- **DIAGNOSTIC_TEST:** [89Zr]Zr-DFO-SHR1920
- **DIAGNOSTIC_TEST:** [18F]F-RESCA-3A12
- **DIAGNOSTIC_TEST:** [68Ga]Ga-NOTA-3A12

## Key facts

- **NCT ID:** NCT06602037
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-20
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06602037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06602037, "ImmunoPET Imaging of Pancreatic Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06602037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*